Provectus’s Substack logo

Provectus’s Substack

by Provectus Biopharmaceuticals
2K+
free subscribers

Provectus’s Substack

About the Substack

A clinical-stage biotechnology company developing immunotherapy medicines for different diseases based on a class of synthetic small molecule halogenated xanthenes, with lead molecule rose bengal sodium.

About Provectus Biopharmaceuticals

We are a clinical-stage biotech developing immunotherapy medicines for different diseases based on a class of small molecules called halogenated xanthenes.

Subscriber Growth

The number of free subscribers for Provectus’s Substack over time since it was added to the directory.

Is this your Substack? Submit changes.